CreAgri, Inc. Announces a Strategic Distribution Agreement for Olivenol(R) plus Line of Dietary Supplements and Skincare Products
2/8/2013 6:30 AM EST
CreAgri, Inc.
Press release
CreAgri, Inc. Announces a Strategic Distribution Agreement for Olivenol(R) plus
Line of Dietary Supplements and Skincare Products
HAYWARD, Calif., 2013-02-08 12:30 CET (GLOBE NEWSWIRE) -- CreAgri, Inc. and
NewWave Biosciences, Inc. announced today that they have reached an agreement
for the distribution of Olivenol® plus products across the therapeutic channel.
Initialized in Hayward, present the Chief executives and the executive team of
the two companies, the agreement envisages the progressive introduction of the
award winning Olivenol® plus line of organic products for health and wellness,
featuring olive polyphenols and hydroxytyrosol, to health care professionals
across the United States.
"Starting today with Florida and rapidly expanding to the rest of the US,
NewWave Biosciences will bring Olivenol® plus into the offices of
rheumatologists, dermatologists, naturopaths, osteopaths and cardiologists
allowing them to provide the opportunity to their patients to leverage the
anti-inflammatory power of HIDROX®—Olivenol's® patented bioactive nutrient
derived from the juice of organic olives—to obtain support and relief in
conditions ranging from arthritis and osteoarthritis to psoriasis, eczema,
contact dermatitis, and cardiovascular stress," affirmed Roberto Crea, PhD, CEO
and President of CreAgri.
Internal Medicine specialist and Chief Medical Strategist for NewWave
Biosciences, Dr. John Langdon has hailed Olivenol® plus as a breakthrough
nutraceutical that bridges the science gap between countless commonly used
nutritional supplements and mainstream well researched pharmaceutical products.
"Olivenol's® potent anti-inflammatory and antioxidant components have been
subjected to both basic bench researches as well as peer reviewed clinical
trials at respected medical centers and demonstrated major ability to prevent
the inflammatory cascade at the root of the most common diseases afflicting
virtually everyone at some point in their life," affirms Dr. Langdon.
"Today, NewWave Biosciences, Inc. is proud to exclusively license Olivenol®
plus in North America and Canada. We considered many factors that solidified
our interest to build a dedicated national sales force across America," states,
Brad Cole, President and Chief Executive Officer, NewWave Biosciences. "Our
research considered solid bench marked studies, a world renowned Scientist in
Roberto Crea, and the ability to help patients to manage severe skin conditions
and chronic inflammation with a natural, organic, and cost effective option to
supplement today's therapies. Customer satisfaction is high with over 85%
compliance over a three year period. We are ready to transform Olivenol® plus
into a valuable household staple, and considering that olives have been around
for thousands of years we are off to a great start."
Totally natural, organic, Halal, Kosher and GRAS, Olivenol® plus has been
recognized with a Nutraceutical Business Technology Award (2011) for health
care management --the highest recognition given to a Nutraceutical product—and
the 2012 Paris Polyphenol Prize, for the most ecological and renewable method
to obtain polyphenols from olive milling water. Assumed daily by tens of
thousands of consumers across the planet, Olivenol® plus is celebrated as one
of the most effective natural antioxidants available on the market today, and a
safe answer to chronic ailments affecting millions worldwide.
About NewWave:
NewWave Biosciences, Inc. Winter Park, Florida, a leading national contracted
sales force built with seasoned biopharmaceutical executives and sales
representatives who are engaged in launching unique, innovative products and
services to help patients and caregivers in the prevention of illness and
disease.
About CreAgri
CreAgri Inc., the inventor and developer of HIDROX® is the manufacturer of
Olivenol plus.
For further information, please visit www.creagri.com, www.olivenolplus.com, or
contact Paolo Pontoniere, .
CONTACT: Paolo Pontoniere
Vice-president of Corporate Communications
510-732-6478